Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIVR Study of Allopurinol Dissolution Profiles
NCT02398448Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Apr 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of allopurinol in gout and hyperuricemia, sponsored by Ardea Biosciences, Inc. Primary endpoint: Pharmacokinetic profile of Zyloprim and test formulations at 96 hours. Started Apr 2015; status: completed.
02
Drugs
allopurinol
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT02398448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02398448.